Eltrombopag Catalog No.:M10203-2 5-dimethyl-4-[(2S)-N

5-dimethyl-4-[(2S)-N

Viral strains that are resistant to zidovudine (AZT) or lamivudine (3TC) are generally

4-benzothiadiazine-7-sulfonamide

Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer

Chemical Name: 1-[(1R

Eltrombopag Catalog No.:M10203-2 5-dimethyl-4-[(2S)-NEltrombopag is a small molecule, nonpeptide thrombopoietin receptor agonist with megakaryopoiesis stimulating activity. Eltrombopag binds to and stimulates the transmembrane domain of the platelet thrombopoietin receptor (TPO R or CD110), a member of the hematopoietin receptor superfamily. Activation of TPO R leads to the proliferation and differentiation of cells in the megakaryocytic lineage and an increase in platelet production. Eltrombopag was